Device is a combination product.Age at time of event: 18 years or older. (b)(4). device evaluated by mfr.: synergy ous mr 3.50 x 12mm stent delivery system was returned for analysis.A visual and microscopic examination of the crimped stent identified stent damage.Damage was noted to stent strut rows 1,2,3,6 and 7 (counting from the distal end of the stent).The crimped stent outer diameter of the undamaged portion of the stent was measured and was within maximum crimped stent profile measurement.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and tactile examination of the hypotube found multiple hypotube kinks.A visual and tactile examination of shaft polymer extrusion revealed no issues.A visual and microscopic examination found damage to the tip.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is operational context as the product meets the design & manufacture specification but due to anatomical/procedural factors encountered during the procedure, performance was limited.(b)(4).
|
Reportable based on device analysis completed on (b)(6) 2018.It was reported that crossing difficulties were encountered and tip damage occurred.The 90% stenosed target lesion was located in the moderately tortuous and severely calcified mid to distal right coronary artery.A 3.50 x 12mm synergy drug-eluting stent (des) was advanced several times but failed to cross the lesion.When the device was removed, it was noted that the tip of the catheter was kinked.Another 3.50 x 12mm synergy des was used and completed the procedure.No patient complications were reported and the patient's status was stable.However, returned device analysis revealed stent damage.
|